| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 23andMe Holding Co. | Chief Financial Officer | Class A Common Stock | 212K | $151K | $0.72 | Aug 20, 2022 | Direct |
| Zura Bio Ltd | Director | Share Option (Right to Buy) | 117K | Dec 9, 2024 | Direct | ||
| ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
| ARENA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZURA | Zura Bio Ltd | Dec 9, 2024 | 1 | $0 | 4 | Dec 11, 2024 | Director |
| ZURA | Zura Bio Ltd | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| ZURA | Zura Bio Ltd | Mar 20, 2023 | 0 | $0 | 3 | Mar 21, 2023 | Director |
| ME | 23andMe Holding Co. | Aug 20, 2022 | 1 | -$15.9K | 4 | Aug 22, 2022 | Chief Financial Officer |
| ME | 23andMe Holding Co. | Jun 1, 2022 | 1 | -$13.5K | 4 | Jun 2, 2022 | Chief Financial Officer |
| ARNA | ARENA PHARMACEUTICALS INC | Mar 11, 2022 | 3 | $0 | 4 | Mar 11, 2022 | Director |
| ME | 23andMe Holding Co. | Feb 9, 2022 | 2 | $0 | 4 | Feb 11, 2022 | Chief Financial Officer |
| ME | 23andMe Holding Co. | Jun 16, 2021 | 0 | $0 | 3 | Jun 25, 2021 | Chief Financial and Accounting Officer Exhibit List Exhibit 24 - Power of Attorney |
| ARNA | ARENA PHARMACEUTICALS INC | Jun 11, 2021 | 4 | $0 | 4 | Jun 15, 2021 | Director |
| ARNA | ARENA PHARMACEUTICALS INC | Jun 11, 2021 | 0 | $0 | 3 | Jun 15, 2021 | Director |